Total cohort |
137 |
15 |
|
Mean age at the time of surgery (year) |
64.5±14.2 |
64.9±19.8 |
0.911 |
Race |
|
|
0.664 |
White
|
114 (83.2)
|
13 ( 86.7)
|
|
AA
|
19 (13.9)
|
1 ( 6.7)
|
|
Hispanic
|
2 ( 1.5)
|
1 ( 6.7)
|
|
Asian
|
2 ( 1.5)
|
0 ( 0.0)
|
|
Female (%) |
68 (49.6) |
9 ( 60.0) |
0.624 |
Height (cm) |
168.5±14.3 |
167.8±12.8 |
0.858 |
Weight (Kg) |
81.2±19.3 |
78.0±23.2 |
0.574 |
Maximal Aortic Size (cm) |
5.3±1.0 |
5.3±1.0 |
0.874 |
Hypertension (%) |
114 (83.2) |
11 ( 73.3) |
0.552 |
Diabetes (%) |
13 ( 9.5) |
2 ( 13.3) |
0.986 |
Dyslipidemia (%) |
63 (46.0) |
4 ( 26.7) |
0.247 |
History of smoking (%) |
59 (43.1) |
8 ( 53.3) |
0.627 |
Marfan syndrome (%) |
6 ( 4.4) |
1 ( 6.7) |
1 |
Neurological comorbidities (%)** |
18 (13.1) |
6 ( 40.0) |
0.02 |
Chronic renal dysfunction (%) |
15 (10.9) |
3 ( 20.0) |
0.542 |
Pulmonary comorbidities (%) |
30 (21.9) |
3 ( 20.0) |
1 |
CAD (%) |
21 (15.3) |
4 ( 26.7) |
0.449 |
Previous Cardiac Surgery (%) |
45 (32.8) |
3 ( 20.0) |
0.469 |
Primary Diagnosis as Dissection (%) |
46 (33.6) |
3 ( 20.0) |
0.437 |
Timing of surgical intervention (%) |
|
|
|
Elective
|
109 (79.6)
|
10 ( 66.7)
|
|
Urgent
|
26 (19.0)
|
3 ( 20.0)
|
|
Emergent
|
2 ( 1.5)
|
2 ( 13.3)
|
|
Aortic Valve Replacement (%) |
|
|
|
None
|
93 (67.9)
|
9 ( 60.0)
|
|
Bioprosthetic
|
26 (19.0)
|
3 ( 20.0)
|
|
Mechanical
|
18 (13.1)
|
3 ( 20.0)
|
|
Composite Graft replacement (%) |
15 (10.9) |
2 ( 13.3) |
1 |
Concomitant CABG (%) |
12 ( 8.8) |
2 ( 13.3) |
0.911 |
Cardiopulmonary bypass time (min) |
160.6±29.6 |
173.1±36.5 |
0.131 |
Aortic Cross-clamp time (min) |
82.9±35.7 |
94.7±38.0 |
0.229 |
DHCA time (min) |
41.9±8.6 |
44.3±11.7 |
0.329 |